Split GFP complementation assay for quantitative measurement of tau aggregation in situ

Methods in Molecular Biology

Volumn 670, Issue , 2011, Pages 109-123

  Chun, Wanjoo ^a   Waldo, Geoffrey S ^b   Johnson, Gail V W ^c  

^a Kangwon National University   (South Korea)

^b LOS ALAMOS NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Aggregation; GSK3 ; Split GFP complementation; Tau

Indexed keywords

GREEN FLUORESCENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; FLUORESCENCE MICROSCOPY; GENETIC COMPLEMENTATION; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS;

EID: 84934435700     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-744-0_9     Document Type: Article

References (13)

1. Johnson, G. V., and Bailey, C. D. (2002) Tau, where are we now? J Alzheimers Dis 4, 375-98.
2. Stoothoff, W. H., and Johnson, G. V. (2005) Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 1739, 280-97.
3. Ding, H., and Johnson, G. V. (2008) The last tangle of tau. J Alzheimers Dis 14, 441-7.
4. Grundke-Iqbal, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., and Wisniewski, H. M. (1986) Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J Biol Chem 261, 6084-9.
5. Kosik, K. S., Joachim, C. L., and Selkoe, D. J. (1986) Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A 83, 4044-8.
6. Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G. Q., and Mucke, L. (2007) Reducing endogenous tau ameliorates amyloid betainduced deficits in an Alzheimer's disease mouse model. Science 316, 750-4.
7. Santacruz, K., Lewis, J., Spires, T., Paulson, J., Kotilinek, L., Ingelsson, M., Guimaraes, A., DeTure, M., Ramsden, M., McGowan, E., Forster, C., Yue, M., Orne, J., Janus, C., Mariash, A., Kuskowski, M., Hyman, B., Hutton, M., and Ashe, K. H. (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476-81.
8. Chun, W., Waldo, G. S., and Johnson, G. V. (2007) Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage. J Neurochem 103, 2529-39.
9. Cabantous, S., Terwilliger, T. C., and Waldo, G. S. (2005) Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 23, 102-7.
10. Khlistunova, I., Biernat, J., Wang, Y., Pickhardt, M., von Bergen, M., Gazova, Z., Mandelkow, E., and Mandelkow, E. M. (2006) Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 281, 1205-14.
11. Cho, J. H., and Johnson, G. V. (2003) Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J Biol Chem 278, 187-93.
12. Meares, G. P., and Jope, R. S. (2007) Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis. J Biol Chem 282, 16989-7001.
13. Cho, J. H., and Johnson, G. V. (2004) Glycogen synthase kinase 3 beta induces caspase- cleaved tau aggregation in situ. J Biol Chem 279, 54716-23.